Argenx Se (ARGX) EPS (Basic) (2016 - 2026)
Argenx Se's (ARGX) quarterly EPS (Basic) came in at $7.59 in Q2 2026, up 88.81% YoY from $4.02 in Q2 2025, and up 28.7% on a QoQ basis from $5.9 in Q1 2026.
Argenx Se (ARGX) EPS (Basic) (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has 11 years of EPS (Basic) data on file, last reported at $7.59 in Q2 2026.
- Quarterly EPS (Basic) rose 88.81% year-over-year to $7.59 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $27.58 (up 31.53% YoY) and the FY2025 annual result came in at $21.08, up 51.46% from the prior year.
- EPS (Basic) improved to $7.59 in Q2 2026, from $5.9 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $12.93 in Q4 2024 to a low of -$4.26 in Q3 2022.
- A 5-year average of $3.06 and a median of $2.25 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) sank 299.85% — and 2025, when it jumped 721.54%.
- Tracing ARGX's EPS (Basic) over 5 years: stood at $0.71 in 2022, then surged by 144.31% to $1.73 in 2023, then surged by 645.59% to $12.93 in 2024, then tumbled by 32.77% to $8.69 in 2025, then dropped by 12.7% to $7.59 in 2026.
- The last three EPS (Basic) figures came in at $7.59 (Q2 2026), $5.9 (Q1 2026), and $8.69 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.59 |
| Mar 31, 2026 | 5.90 |
| Dec 31, 2025 | 8.69 |
| Sep 30, 2025 | 5.61 |
| Jun 30, 2025 | 4.02 |
| Mar 31, 2025 | 2.77 |
| Dec 31, 2024 | 12.93 |
| Sep 30, 2024 | 1.52 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | -1.04 |
| Dec 31, 2023 | 1.73 |
| Sep 30, 2023 | 1.25 |
| Jun 30, 2023 | -1.69 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.71 |
| Sep 30, 2022 | -4.26 |
| Jun 30, 2022 | 3.91 |
| Mar 31, 2022 | 4.36 |
| Dec 31, 2021 | -4.66 |
| Sep 30, 2021 | -4.54 |